How prominent are patient-reported outcomes in clinical trials of dermatological treatments?

British Journal of Dermatology

Volumn 159, Issue 5, 2008, Pages 1152-1159

  Townshend, A P ^a   Chen, C M ^b   Williams, H C ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Clinical trials; Data reporting; Patient reported outcomes

Indexed keywords

ARTICLE; CLINICAL TRIAL; COCHRANE LIBRARY; DERMATOLOGY; HUMAN; OUTCOME ASSESSMENT; PATIENT PARTICIPATION; PHYSICIAN; PRIORITY JOURNAL; SELF REPORT; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

DERMATOLOGIC AGENTS; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT PARTICIPATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; SKIN DISEASES; TREATMENT OUTCOME;

EID: 54249104604     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2008.08799.x     Document Type: Article

References (46)

1. Charman C, Chambers C, Williams H. Measuring atopic dermatitis severity in randomized controlled clinical trials: what exactly are we measuring? J Invest Dermatol 2003 120 : 932 41.
2. Charman C, Williams H. Outcome measures of disease severity in atopic eczema. Arch Dermatol 2000 136 : 763 9.
3. Jacobson CC, Kimball AB. Rethinking the Psoriasis Area and Severity Index: the impact of area should be increased. Br J Dermatol 2004 151 : 381 7.
4. van de Kerkhof PCM. On the limitations of the Psoriasis Area and Severity Index (PASI). Br J Dermatol 1992 126 : 205.
5. Jacobe HT, Leitenberger JJ, Bergstresser PR. Understanding clinical trial outcomes: design, analysis, and interpretation. Dermatol Ther 2007 20 : 77 85.
6. Shikiar R, Bresnahan BW, Stone SP et al. Validity and reliability of patient reported outcomes used in psoriasis: results from two randomized clinical trials. Health Qual Life Outcomes 2003 1 : 53.
7. Hoare C, Li Wan Po A, Williams H. Systematic review of treatments for atopic eczema. Health Technol Assess 2000 4 : 1 191.
8. Grob J. Why are quality of life instruments not recognised as reference measures in therapeutic trials of chronic skin disorders? J Invest Dermatol 2007 127 : 2299 301.
9. Anonymous. Doing better, feeling worse. Lancet 1990 336 : 1037 8.
10. Delamere FM, Williams HC. How can hand searching the dermatological literature help people with skin problems? Arch Dermatol 2001 137 : 332 5.
11. DeVillez RL, Jacobs JP, Szpunar CA, Warner ML. Androgenetic alopecia in the female. Treatment with 2% topical minoxidil solution. Arch Dermatol 1994 130 : 303 7.
12. Drake LA, Millikan LE. The antipruritic effect of 5% doxepin cream in patients with eczematous dermatitis. Doxepin Study Group. Arch Dermatol 1995 131 : 1403 8.
13. van de Kerkhof PCM, Cambazard F, Hutchinson PE et al. The effect of the addition of calcipotriol ointment (50 μg/g) to acitretin therapy in psoriasis. Br J Dermatol 1998 138 : 84 9.
14. Davies DB, Boorman GC, Shuttleworth D. Comparative efficacy of shampoos containing coal tar (4.0% w/w; Tarmed™), coal tar (4.0% w/w) plus ciclopirox olamine (1.0% w/w; Tarmed™ AF) and ketoconazole (2.0% w/w; Nizoral™) for the treatment of dandruff/seborrhoeic dermatitis. J Dermatolog Treat 1999 10 : 177 83.
15. Lok C, Paul C, Amblard P et al. EMLA cream as a topical anesthetic for the repeated mechanical debridement of venous leg ulcers: a double-blind, placebo-controlled study. J Am Acad Dermatol 1999 40 : 208 13.
16. Chu A, Huber FJ, Plott RT. The comparative efficacy of benzoyl peroxide 5%/erythromycin 3% gel and erythromycin 4%/zinc 1.2% solution in the treatment of acne vulgaris. Br J Dermatol 1997 136 : 235 8.
17. Naldi N, Svensson A, Diepgen T et al. on behalf of The European Dermato-Epidemiology Network (EDEN). Randomized clinical trials for psoriasis 1997-2000: The EDEN survey. J Invest Dermatol 2003 120 : 738 41.
18. Agency for Healthcare Research and Quality. Management of Acne. Summary, Evidence Report/Technology Assessment: Number 17. AHRQ Publication No. 01-E018. Rockville, MD : Agency for Healthcare Research and Quality, 2001. Available at: http://www.ahrq.gov/clinic/epcsums/acnesum.htm (last accessed 24 April 2008).
19. Bigby M, Stern RS, Bigby JA. An evaluation of method reporting and use in clinical trials in dermatology. Arch Dermatol 1985 121 : 1394 9.
20. Adetugbo K, Williams H. How well are randomized controlled trials reported in the dermatology literature? Arch Dermatol 2000 136 : 381 5.
21. Krueger GG, Langley RG, Finlay AY et al. Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trial. Br J Dermatol 2005 153 : 1192 9.
22. Olsen EA. Topical minoxidil in the treatment of androgenetic alopecia in women. Cutis 1991 48 : 243 8.
23. Cochrane Skin Group. Published Protocols. Available at: http://www.csg.cochrane.org/about/pubdprotos.htm (last accessed 5 August 2008).
24. Guillaume JC, Moulin G, Dieng MT et al. Crossover study of thalidomide vs placebo in Jessner's lymphocytic infiltration of the skin. Arch Dermatol 1995 131 : 1032 5.
25. Stiller MJ, Bartolone J, Stern R et al. Topical 8% glycolic acid and 8%l-lactic acid creams for the treatment of photodamaged skin. A double-blind vehicle-controlled clinical trial. Arch Dermatol 1996 132 : 631 6.
26. Molin L, Cutler TP, Helander I et al. Comparative efficacy of calcipotriol (MC903) cream and betamethasone 17-valerate cream in the treatment of chronic plaque psoriasis. A randomized, double-blind, parallel group multicentre study. Calcipotriol Study Group. Br J Dermatol 1997 136 : 89 93.
27. Ruzicka T, Lorenz B. Comparison of calcipotriol monotherapy and a combination of calcipotriol and betamethasone valerate after 2 weeks' treatment with calcipotriol in the topical therapy of psoriasis vulgaris: a multicentre, double-blind, randomized study. Br J Dermatol 1998 138 : 254 8.
28. Oliwiecki S, Burton JL. Evening primrose oil and marine oil in the treatment of psoriasis. Clin Exp Dermatol 1994 19 : 127 9.
29. Simons JR, Bohnen IJWE, van der Valk PGM. A left-right comparison of UVB phototherapy and topical photochemotherapy in bilateral chronic hand dermatitis after 6 weeks' treatment. Clin Exp Dermatol 1997 22 : 7 10.
30. Glade CP, van der Vleuten CJ, van Erp PE et al. The epidermis of chronic idiopathic lichen planus during topical treatment with the vitamin D3 analogue KH 1060. Clin Exp Dermatol 1998 23 : 14 18.
31. Green C, Orchard G, Cerio R, Hawk JLM. A clinicopathological study of the effects of topical retinyl propionate cream in skin photoageing. Clin Exp Dermatol 1998 23 : 162 7.
32. Watson NT, Weiss EL, Harter PM. Famotidine in the treatment of acute urticaria. Clin Exp Dermatol 2000 25 : 186 9.
33. Pigatto PD, Bigardi AD, Cannistraci C, Picardo M. 10% urea cream (Laceran) for atopic dermatitis: a clinical and laboratory evaluation. J Dermatolog Treat 1996 7 : 171 5.
34. Ortonne JP. A controlled study of the activity of hyaluronic acid in the treatment of venous leg ulcers. J Dermatolog Treat 1996 7 : 75 81.
35. Reidhav I, Svensson A. Betamethasone valerate versus mometasone furoate cream once daily in atopic dermatitis. J Dermatolog Treat 1996 7 : 87 8.
36. Patel P, Gratton D, Eckstein G et al. A double-blind study of loratadine and cetirizine in atopic dermatitis. J Dermatolog Treat 1997 8 : 249 53.
37. Katz HI, Tanner DJ, Cuffie CA et al. A comparison of the efficacy and safety of the combination mometasone furoate 0.1%/salicylic acid 5% ointment with each of its components in psoriasis. J Dermatolog Treat 1998 9 : 151 6.
38. ®) for the control of dandruff/seborrhoeic dermatitis. J Dermatolog Treat 1998 9 : 157 62.
39. Shuttleworth D, Galloway DB, Boorman GC, Donald AE. A double-blind, placebo-controlled study of the clinical efficacy of ciclopirox olamine (1.5%) shampoo for the control of scalp psoriasis. J Dermatolog Treat 1998 9 : 163 7.
40. van 't Veen AJ, Prevoo RLMA, Velders AJ et al. Betamethasone-17-valerate compared with ketoconazole for topical treatment of seborrhoeic dermatitis of the scalp in adults. Results of a Dutch multicentre study. J Dermatolog Treat 1998 9 : 239 45.
41. Christensen OB, Mork NJ, Ashton R et al. Comparison of a treatment phase and a follow-up phase of short-contact dithranol and calcipotriol in outpatients with chronic plaque psoriasis. J Dermatolog Treat 1999 10 : 261 5.
42. Farkas B, Dobozy A, Horváth A et al. Comparison of tacalcitol ointment with short-contact dithranol therapy in the treatment of psoriasis vulgaris: a randomized multicentre, open prospective study on efficacy and safety. J Dermatolog Treat 1999 10 : 93 9.
43. Miller BH, Shavin JS, Cognetta A et al. Nonsurgical treatment of basal cell carcinomas with intralesional 5-fluorouracil/epinephrine injectable gel. J Am Acad Dermatol 1997 36 : 72 7.
44. Oranje AP, Marcoux D, Svensson A et al. Topical calcipotriol in childhood psoriasis. J Am Acad Dermatol 1997 36 : 203 8.
45. Mayser P, Mrowietz U, Arenberger P et al. Omega-3 fatty acid-based lipid infusion in patients with chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, multicenter trial. J Am Acad Dermatol 1998 38 : 539 47.
46. Leyden J, Dunlap F, Miller B et al. Finasteride in the treatment of men with frontal male pattern hair loss. J Am Acad Dermatol 1999 40 : 930 7.